SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SNSS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/06/10	07:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07:27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07:23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/06/10	07:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/27	08:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/27	08:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/27	08:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/09	05:24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/06	05:53	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/05/03	05:34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/04/28	05:16	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/04/28	05:09	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/04/01	05:36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/18	06:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/15	06:14	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/01	08:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/01	08:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/03/01	08:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/02/14	20:03	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2023/01/11	07:22	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07:34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/30	07:18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/11	06:38	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/11/11	06:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc
2022/09/20	08:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNSS	Sunesis Pharmaceuticals Inc